On June 20, the University of New Hampshire published the poll results of its numerous state topics such as Gov. Chris Sununu’s job performance, housing as the most important problem statewide, and cannabis legalization. Recently, a cannabis legalization bill (House Bill 1633) which was rejected by legislators in a 178-173 vote on June 13. To… Keep Reading
A recent study published in Biocatalysis and Agricultural Biotechnology analyzed the possibilities of genetically engineering cannabis to ensure consistency and targeting specifical cannabinoids. In “Using Advanced Biotechnological Techniques to Improve Cannabis Cultivars,” researchers from the University of Lethbridge’s Department of Biological Sciences in Alberta, Canada, explored the benefits of gene editing in cannabis. “Inherent breeding… Keep Reading
Cannabis does not cause “next-day impairment” researchers found in a new study published last week in the journal Psychopharmacology. Researchers found little evidence to suggest that THC can impact a person’s performance the next day, though any experienced smoker could tell you the same. Researchers observed 20 adults with physician-diagnosed insomnia who consumed cannabis irregularly,… Keep Reading
In an interview with Taste of Country published on May 24, Grammy Award-nominated country artist Jason “Jelly Roll” DeFord said that he smokes weed to stay away from hard drugs that he’s used in the past—namely opioids and benzodiazepines. Given his past as an addict and his role in speaking against the use of fentanyl… Keep Reading
A newly published study from researchers at New York University found that individuals dealing with a stutter derived some benefit from substances such as psilocybin, the psychoactive compound in “magic mushrooms,” and LSD. “Given the positive effects of psychedelics on conditions like anxiety and PTSD, which share symptoms with stuttering, we think that investigating the… Keep Reading
The federal government is finalizing the reclassification of cannabis. The U.S. Department of Justice published a proposed rule in the U.S. Federal Register to reclassify cannabis from Schedule I of the federal Controlled Substances Act (CSA) and move it to Schedule III. For over 50 years, cannabis has been classified as a Schedule I controlled… Keep Reading
In a study that was originally published late last year, researchers unveiled the risks for former cocaine users who may relapse by taking methylphenidate. Methylphenidate is used as a treatment for attention-deficit hyperactivity disorder (ADHD), and is often recognized through brands such as Aptensio XR, Concerta/Concerta XR-ODT, Jornay PM, and most commonly, Ritalin. As a… Keep Reading
New research, which was published in the journal Cannabis, shows evidence of the weight loss effects of cannabinoids such as THCV and CBD. The study’s official title is “Weight Loss and Therapeutic Metabolic Effects of Tetrahydrocannabivarin (THCV)-Infused Mucoadhesive Strips,” and studied participants’ use of oral strips to administer a combination of THCV/CBD or a placebo.… Keep Reading
Researchers from Romania published the results of a study in the International Journal of Molecular Sciences exploring and analyzing the effects of various phytocannabinoids and terpenes working together. Phytocannabinoids include any naturally occurring cannabinoid found in the plant, from the more commonly known THC, and CBD to less known CBC, CBG, CBN, and more. Researchers… Keep Reading
Newly published research indicates that recreational cannabis legalization in Washington did not result in a spike in impaired driving among younger demographics. The research, published last month in the journal Prevention Science, was based on data collected in the five years following legalization. “Motor vehicle crashes are a leading cause of death for young adults… Keep Reading
